Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Joseph L. Chin"'
Autor:
Andrew Loblaw, Nathan Perlis, Janet E. Brown, Xiaomei Yao, N. Schieda, Masoom A. Haider, Joseph L. Chin
Publikováno v:
Clinical Oncology. 33:e599-e612
There has been growing utilisation of multiparametric magnetic resonance imaging (MPMRI) as a non-invasive tool to diagnose and localise clinically significant prostate cancer (CSPCa). This updated systematic review examines the use of MPMRI in patie
Autor:
Melissa Huynh, Nicholas Power, Shiva M. Nair, Khalil Hetou, Jonathan I. Izawa, Daniel Halstuch, Ailsa May Li Gan, Joseph L. Chin, Arnon Lavi
Publikováno v:
Urology. 154:33-39
Objective To determine if a modified cystoscopy technique utilizing the peak-end rule cognitive bias decreases pain and anxiety during flexible cystoscopy in patients who undergo cystoscopy. Methods A total of 85 participants undergoing their first d
Autor:
Christopher W. Smith, Joseph L. Chin, Madeleine Moussa, Irina Rachinsky, Glenn Bauman, Aaron D. Ward, Douglas A. Hoover, Stephen E. Pautler, Jonathan D. Thiessen, Ryan Alfano, Mena Gaed, John Butler, Kathleen Surry, David D'Souza, Jose A. Gomez
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 19, Iss, Pp 102-107 (2021)
Physics and Imaging in Radiation Oncology
Physics and Imaging in Radiation Oncology
Highlights • This paper evaluated lesion-directed prostatic high dose rate brachytherapy. • Lesions defined by prostate specific membrane antigen positron emission tomography. • Dose escalation was confirmed using whole-mount digital histology.
Autor:
John F. Valliant, Dae-Myoung Yang, Fiona Li, Madeleine Moussa, Stephen E. Pautler, Joseph L. Chin, Irina Rachinsky, Ting-Yim Lee, Glenn Bauman
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-10 (2021)
EJNMMI Research
Medical Biophysics Publications
EJNMMI Research
Medical Biophysics Publications
Purpose Identification of the dominant intraprostatic lesion(s) (DILs) can facilitate diagnosis and treatment by targeting biologically significant intra-prostatic foci. A PSMA ligand, [18F]DCFPyL (2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine-3-carbony
Autor:
James Relle, Khalil Hetou, Shiva M. Nair, Sascha Pahernik, Jason Hafron, Matthias Roethke, Joseph L. Chin, Gencay Hatiboglu, David Bonekamp, Zahra Kassam, Mathieu Burtnyk, Christopher Harle, Heinz Peter Schlemmer, Robert Staruch, Maya Mueller-Wolf
Publikováno v:
BJU International. 127:544-552
OBJECTIVES To report the 3-year follow-up of a Phase I study of magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) in 30 men with localised prostate cancer. Favourable 12-month safety and ablation precision were previou
Autor:
Jonathan D. Thiessen, Jose A. Gomez, Stephen E. Pautler, William Pavlosky, Mena Gaed, Madeleine Moussa, John Butler, Wei Liu, Aaron D. Ward, Ryan Alfano, Glenn Bauman, Joseph L. Chin, Irina Rachinsky
Publikováno v:
Medical Biophysics Publications
Background PSMA-PET 1 has shown good concordance with histology, but there is a need to investigate the ability of PSMA-PET to delineate DIL 2 boundaries for guided biopsy and focal therapy planning. Objective To determine threshold and margin combin
Autor:
Darrel E. Drachenberg, Martin E. Gleave, D. Robert Siemens, Stephen E. Pautler, Douglas C. Cheung, Simon Tanguay, Jenna Sykes, Masoom A. Haider, John R. Kachura, Andrew J. Evans, Neil Fleshner, Joseph L. Chin, Ashraf Almatar, Christopher Morash, Michael A.S. Jewett, Ricardo A. Rendon, Antonio Finelli
Publikováno v:
European Urology. 78:460-467
Background Most reports of active surveillance (AS) of small renal masses (SRMs) lack biopsy confirmation, and therefore include benign tumors and different subtypes of renal cell carcinoma (RCC). Objective We compared the growth rates and progressio
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 2, Pp 212-220 (2020)
Medical Biophysics Publications
Advances in Radiation Oncology
Medical Biophysics Publications
Advances in Radiation Oncology
Purpose Prostate cancer is multifocal. However, there often exists a single dominant focus in the gland responsible for driving the biology of the disease. Dose escalation to the dominant lesion is a proposed strategy to increase tumor control. We ap
Autor:
David M. Berman, Andrew Loblaw, Linda Sugar, Marlene Kebabdjian, Masoom A. Haider, Theo van der Kwast, Joseph L. Chin, Danny Vesprini, Laurence Klotz, Neil Fleshner, Laurent Milot, Greg Pond, Sangheet Ghai, Madeline Moussa
Publikováno v:
European Urology. 77:311-317
Background The initial report from the ASIST trial showed little benefit from targeted biopsy for men on active surveillance (AS) for prostate cancer. Data after 2-yr follow-up are now available for analysis. Objective To determine if there was a dif
Autor:
Aaron D. Ward, Kevin J. Chung, Mena Gaed, Dae-Myoung Yang, Joseph L. Chin, Glenn Bauman, Jonathan D. Thiessen, Stephen E. Pautler, Ryan Alfano, Madeleine Moussa, Irina Rachinsky, Ting-Yim Lee, Jose A. Gomez
Publikováno v:
EJNMMI Research
EJNMMI Research, Vol 11, Iss 1, Pp 1-9 (2021)
EJNMMI Research, Vol 11, Iss 1, Pp 1-9 (2021)
Purpose Localized prostate cancer (PCa) in patients is characterized by a dominant focus in the gland (dominant intraprostatic lesion, DIL). Accurate DIL identification may enable more accurate diagnosis and therapy through more precise targeting of